Deregulation of splicing factors and breast cancer development
M Silipo, H Gautrey… - Journal of molecular cell …, 2015 - academic.oup.com
It is well known that many genes implicated in the development and progression of breast
cancer undergo aberrant alternative splicing events to produce proteins with pro-cancer …
cancer undergo aberrant alternative splicing events to produce proteins with pro-cancer …
TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth
S Haricharan, P Brown - Proceedings of the National …, 2015 - National Acad Sciences
Breast cancer is a leading cause of cancer-related death, and it is important to understand
pathways that drive the disease to devise effective therapeutic strategies. Our results show …
pathways that drive the disease to devise effective therapeutic strategies. Our results show …
JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression
X Shen, Z Zhuang, Y Zhang, Z Chen, L Shen, W Pu… - Tumor Biology, 2015 - Springer
Although three therapeutic modalities (surgical resection, chemotherapy, and radiotherapy)
have been established, long-term survival for lung cancer patients is still generally poor …
have been established, long-term survival for lung cancer patients is still generally poor …
Гетерогенность раннего рака молочной железы: биологическое, популяционное и прогностическое значение
ИВ Колядина - 2015 - elibrary.ru
Рак молочной железы (РМЖ)—наиболее распространенная женская онкопатология во
всем мире с огромными медицинскими, демографическими и социально …
всем мире с огромными медицинскими, демографическими и социально …
The personalization of therapy: molecular profiling technologies and their application
J Zeron-Medina, MO De Olza, I Braña, J Rodon - Seminars in oncology, 2015 - Elsevier
Advances in tumor biology and human genetics that have identified driver events and critical
dependencies, together with the development of drugs for specific targets, hold promise for …
dependencies, together with the development of drugs for specific targets, hold promise for …
[PDF][PDF] Evaluation of aberrant p16 INK4α promoter CpG methylation and its application in Vietnamese breast cancers patients
The disruption of genetic materials as the aberrant methylation at CpG islands of tumor
suppressor gene's promoter, which is thought to be a driver epigenetic events of malignant …
suppressor gene's promoter, which is thought to be a driver epigenetic events of malignant …
[PDF][PDF] EVALUATION OF TP53 GENE EXPRESSION IN FFPE OF BREAST CANCER PATIENTS
MK HUSSAIN, DAF ALKOOFEE, AS JUMAAH - impactjournals.us
3.applied- Evaluation of TP53 gene-Dr. Dhafer AF Al-Koofee Page 1 Impact Factor(JCC): 1.4507
- This article can be downloaded from www.impactjournals.us IMPACT: International Journal of …
- This article can be downloaded from www.impactjournals.us IMPACT: International Journal of …